Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 (PASTEUR Act of 2026), entire bill
Literal federal measure citations: H.R.7352
2026 · 1st Quarter (Jan 1 - Mar 31)
INFECTIOUS DISEASES SOCIETY OF AMERICA
Filed by ARENTFOX SCHIFF LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 17, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- ARENTFOX SCHIFF LLP
- Filing UUID
- 175697f3-c97f-4324-89ec-e81ef5ba465a
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill H.R.7148 (Consolidated Appropriations Act, 2026), Division B, Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally Fiscal Year 2027 funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally
Literal federal measure citations: H.R. 5304, S. 2587, H.R. 4445, H.R.7148
Medicare reimbursement regarding evaluation and management services by infectious disease physicians and practice expense policies
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.